Comparisons of Two Types of Robot Assisted Gait Training

November 13, 2017 updated by: Joon-Ho Shin, National Rehabilitation Center, Seoul, Korea

Comparisons of Two Types of Robot Assisted Gait Training: Exoskeleton Type Robot vs. End-effector Type Robot: Randomized Controlled Trial

Comparisons of Two Types of Robot Assisted Gait Training: Exoskeleton Type Robot vs. End-effector Type Robot: Randomized Controlled Trial

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Seoul, Korea, Republic of, 142884
        • Recruiting
        • National Rehabilitation Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years to 80 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Hemiplegic patients secondary to first cerebrovascular accidents
  • Ankle dorsiflexor strength: medical research council scale 2 or 3
  • Functional ambulation category score 3

Exclusion Criteria:

  • History of surgery of affected lower limb
  • Fracture of affected lower limb

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: exoskeleton type robot
exoskeleton type robot assisted gait training (Lokomat orthosis)
EXPERIMENTAL: end-effector type robot
end-effector type robot assisted gait training (G-EO system)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of Range of motion of ankle joint at 4 weeks
Time Frame: 4 weeks from baseline
ankle joint motion of sagittal plane during gait
4 weeks from baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Trunk impairment scale
Time Frame: Baseline, 4 weeks from baseline, 8 weeks from baseline
Trunk impairment scale performs to evaluate the sitting balance and trunk control ability examining static sitting balance, dynamic sitting balance, and coordination, and the maximum score on the subscales are 7, 10, and 6 points, repectively. The total score ranges from 0 to 23 points, a higher score indicating a better trunk performance.
Baseline, 4 weeks from baseline, 8 weeks from baseline
Berg Balance Scale
Time Frame: Baseline, 4 weeks from baseline, 8 weeks from baseline
Berg Balance Scale assess the functional balance ability of participants with observation of 14 tasks, representing functional movements common in daily life. Each task is scored on a five-point scale (0-4) floolwing the guidelines of the test develpers, and the maximum score on this test is 56 which indicates balance ability within the normal range.
Baseline, 4 weeks from baseline, 8 weeks from baseline
10m walk test
Time Frame: Baseline, 4 weeks from baseline, 8 weeks from baseline
10m walk test is used to examine gait speed, in which participant was asked to walk on a 14 meter of walkway wearing harness with two conditions; with the fastest speed or with self-selected comfortable speed.
Baseline, 4 weeks from baseline, 8 weeks from baseline
Fugl-Meyer Assessment
Time Frame: Baseline, 4 weeks from baseline, 8 weeks from baseline
Fugl-Meyer Assessment uses to examine the motor function and coordination of affected lower extremity. It includes 17 items of a 3-point ordinal scale, ranging 0-34, with higher scores indicating lower impairment.
Baseline, 4 weeks from baseline, 8 weeks from baseline
Korean version of Falls efficacy scale
Time Frame: Baseline, 4 weeks from baseline, 8 weeks from baseline
Korean version of Falls efficacy scale asks subjects to rank their confidence about their ability not to fall while performing a variety of activities of daily living with a maximum score of 100
Baseline, 4 weeks from baseline, 8 weeks from baseline
Range of motion of hip joint
Time Frame: Baseline, 4 weeks from baseline, 8 weeks from baseline
Hip joint motion of sagittal plane during gait
Baseline, 4 weeks from baseline, 8 weeks from baseline
Range of motion of knee joint
Time Frame: Baseline, 4 weeks from baseline, 8 weeks from baseline
knee joint motion of sagittal plane during gait
Baseline, 4 weeks from baseline, 8 weeks from baseline
Range of motion of ankle joint
Time Frame: Baseline, 8 weeks from baseline
ankle joint motion of sagittal plane during gait
Baseline, 8 weeks from baseline
Electromyography of lower extremities
Time Frame: Baseline, 4 weeks from baseline, 8 weeks from baseline
Muscle activity of tibialis anterior, medial gastrocnemius, vastus medialis, biceps femoris, gluteus medius during gait.
Baseline, 4 weeks from baseline, 8 weeks from baseline
Plantar pressure
Time Frame: Baseline, 4 weeks from baseline, 8 weeks from baseline
Plantar pressure (great toe, little toe, medial meta, lateral meta, medial arch, lateral arch, heel) during gait
Baseline, 4 weeks from baseline, 8 weeks from baseline
Step length, time
Time Frame: Baseline, 4 weeks from baseline, 8 weeks from baseline
Step length, stance time, swing time, and stride time during gait
Baseline, 4 weeks from baseline, 8 weeks from baseline
Functional Ambulation Category
Time Frame: Baseline, 4 weeks from baseline, 8 weeks from baseline
Functional Ambulation Category is used to assess gait ability with 6 levels ranging from 0 to 5 on the basis of the amount of physical support required, regardless of use of an assistive device
Baseline, 4 weeks from baseline, 8 weeks from baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2016

Primary Completion (ANTICIPATED)

December 1, 2017

Study Completion (ANTICIPATED)

December 1, 2017

Study Registration Dates

First Submitted

October 22, 2017

First Submitted That Met QC Criteria

November 8, 2017

First Posted (ACTUAL)

November 14, 2017

Study Record Updates

Last Update Posted (ACTUAL)

November 17, 2017

Last Update Submitted That Met QC Criteria

November 13, 2017

Last Verified

November 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • NRC-2016-01-006

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on exoskeleton type robot

3
Subscribe